ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.710,91
0,15%
S&P 500
5.307,01
-0,27%
Dow Jones
39.671,04
-0,51%
Euro vs US Dollar
1,0846
0,19%
Bitcoin
69.636,63
0,77%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cellect Biotechnology Ltd (APOP)

  7. Cellect Biotechnology Ltd (APOP) News

APOP

Cellect Biotechnology (APOP)

Cellect Biotechnology Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:APOP
DatumZeitQuelleÜberschriftSymbolFirma
28/06/202321h04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
28/06/202321h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APOPCellect Biotechnology Ltd
12/05/202322h34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APOPCellect Biotechnology Ltd
09/05/202322h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
09/05/202321h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APOPCellect Biotechnology Ltd
08/05/202323h15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APOPCellect Biotechnology Ltd
22/03/202311h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
20/03/202311h06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APOPCellect Biotechnology Ltd
15/03/202319h40Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:APOPCellect Biotechnology Ltd
03/03/202322h20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APOPCellect Biotechnology Ltd
28/02/202312h14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
28/02/202312h14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
28/02/202312h13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
23/02/202312h05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:APOPCellect Biotechnology Ltd
14/02/202320h41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APOPCellect Biotechnology Ltd
14/02/202317h26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APOPCellect Biotechnology Ltd
13/02/202312h10Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APOPCellect Biotechnology Ltd
09/02/202312h05Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:APOPCellect Biotechnology Ltd
03/02/202312h03Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202315h48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202315h45Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202315h44Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202315h41Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202315h38Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
10/11/202218h45Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
10/11/202218h44Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
10/11/202217h09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APOPCellect Biotechnology Ltd
07/11/202220h46Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
07/11/202220h45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APOPCellect Biotechnology Ltd
28/10/202212h06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
 Showing the most relevant articles for your search:NASDAQ:APOP

Kürzlich von Ihnen besucht

COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
TG
D7G
Nel ASA
PM
XAUUSD
Gold vs US Dollar
CCOM
US100
US Tech 100
NYSE
NKE
Nike
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AAPL
Apple
TG
CBK
Commerzbank
DBI
TDXP
Tec DAX
AMEX
SPY
SPDR S&P 500
DBI
MDAX
MDAX
TG
432
Arbor Metals
DBI
SDXP
SDAX
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten